Kansas City Royals Must Overcome Tough June Schedule to Keep Hopes Alive
It was a rocky May for the Kansas City Royals, and it doesn’t seem that June will be any easier. The Royals have a four-game series with the New York Yankees, St. Louis Cardinals and their dreaded rivals, the Detroit Tigers. Prior to today’s finals, teams playing a full series with the Royals in June are a combined 226-208 this year. Four of these eight teams would make the playoffs if the regular season ended at midnight.
Dwarfing the importance of the two exciting series with the Cards and Yanks is the upcoming four games against the powerhouse divisional leaders. The most anticipated series of the month will come against the Tigers and begin on June 16. The 31-20 Tigers are running away with the AL Central as of now, so these four games in Detroit will go a long way towards determining if KC has a chance to win their division this season.
The worst team, or at least the team with the worst current record that KC will play this upcoming month, is the Cleveland Indians. Only four teams in the MLB have worse records than Cleveland, whose starters’ ERA is lower than that of only three other teams in the league. The Indians and the 26-28 Seattle Mariners are the only losing teams with a series against KC this June.
KC’s pitching will need to fight through a gauntlet of strong lineups this month, which will really test the lasting power of low ERA’s from the likes of Jason Vargas and much of the bullpen. You can find four different teams that play KC in June on the top-10 lists for runs scored, hits, doubles, RBI, batting average and on-base percentage.
5 Players Houston Astros Need to Trade For In 2015
The Houston Astros are much improved, but need to continue to bolster their 25-man roster in order to improve their chances of contending in 2015. Read More
5 Players Tampa Bay Rays Need To Trade For In 2015
The Tampa Bay Rays remain on the cusp of contention despite a minor offseason overhaul that included the departure of super utility-man Ben Zobrist. Read More